Exelixis Competitors and Similar CompaniesClear all
Genocea Biosciences's competitors and similar companies include Northwest Biotherapeutics.
 Genocea Biosciences Genocea Biosciences is a biopharmaceutical company developing T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer. |  Northwest Biotherapeutics Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer. | |
Founding Date | Founding Date 2006 | Founding Date 1998 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Cambridge, US HQ | Locations Bethesda, US HQ |
Employees | Employees 593% decrease | Employees 1721% increase |
Valuation ($) | Valuation ($) 5.7 k | Valuation ($) 349.5 m |
Financial | ||
Revenue (est.) | Revenue (est.) $1.6m (FY, 2021) | Revenue (est.) $1.4m (FY, 2025) |
Net income | Net income ($33.2m) (FY, 2021) | Net income ($60.2m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 209.5m | Total funding raised $ 135.9m |
For sources of this data, please see the company profile
View Company Profiles
Northwest Biotherapeutics
HQ
Bethesda, US
Employees
17↑ 21% increase
Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
View company